These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31802559)

  • 1. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
    Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ
    Phytother Res; 2020 May; 34(5):1123-1133. PubMed ID: 31802559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
    Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
    J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
    Samsami-Kor M; Daryani NE; Asl PR; Hekmatdoost A
    Arch Med Res; 2015 May; 46(4):280-5. PubMed ID: 26002728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers response to two dosages of vitamin D supplementation in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study.
    Karimi S; Tabataba-Vakili S; Ebrahimi-Daryani N; Yari Z; Karimi A; Hedayati M; Hekmatdoost A
    Clin Nutr ESPEN; 2020 Apr; 36():76-81. PubMed ID: 32220372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis.
    Wang Y; Tang Q; Duan P; Yang L
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):476-482. PubMed ID: 30111198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial.
    Masoodi M; Mahdiabadi MA; Mokhtare M; Agah S; Kashani AHF; Rezadoost AM; Sabzikarian M; Talebi A; Sahebkar A
    J Cell Biochem; 2018 Nov; 119(11):9552-9559. PubMed ID: 30132960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.
    Harris MS; Hartman D; Lemos BR; Erlich EC; Spence S; Kennedy S; Ptak T; Pruitt R; Vermeire S; Fox BS
    J Crohns Colitis; 2016 Jun; 10(6):631-40. PubMed ID: 26822613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.
    Panahi Y; Sahebkar A; Parvin S; Saadat A
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):580-8. PubMed ID: 23038702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
    Simadibrata M; Halimkesuma CC; Suwita BM
    Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Curcumin add-on therapy for ulcerative colitis].
    Salomon N; Lang A; Gamus D
    Harefuah; 2015 Jan; 154(1):56-8, 66. PubMed ID: 25796678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.
    Erol Doğan Ö; Karaca Çelik KE; Baş M; Alan EH; Çağın YF
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial.
    Rahimnia AR; Panahi Y; Alishiri G; Sharafi M; Sahebkar A
    Drug Res (Stuttg); 2015 Oct; 65(10):521-5. PubMed ID: 25050518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Iqbal U; Anwar H; Quadri AA
    Am J Med Sci; 2018 Oct; 356(4):350-356. PubMed ID: 30360803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial.
    Amiri M; Navabi J; Shokoohinia Y; Heydarpour F; Bahrami G; Behbood L; Derakhshandeh P; Momtaz S; Farzaei MH
    Complement Ther Med; 2019 Aug; 45():262-268. PubMed ID: 31331572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial.
    Firoozi D; Masoumi SJ; Mohammad-Kazem Hosseini Asl S; Labbe A; Razeghian-Jahromi I; Fararouei M; Lankarani KB; Dara M
    Lipids Health Dis; 2024 Jul; 23(1):216. PubMed ID: 39003477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
    Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.